Serum 3-Nitrotyrosine in the Cardiovascular Disease of Patients with Systemic Lupus Erythematosus

被引:0
作者
Quevedo-Abeledo, Juan C. [1 ]
Hernandez-Diaz, Marta [2 ]
Garcia-Gonzalez, Maria [2 ]
Gomez-Bernal, Fuensanta [3 ]
Almeida-Santiago, Cristina [1 ]
Heras-Recuero, Elena [4 ]
de Vera-Gonzalez, Antonia [3 ]
Gonzalez-Delgado, Alejandra [3 ]
Abreu-Gonzalez, Pedro [5 ]
Tejera-Segura, Beatriz [6 ]
Martin-Gonzalez, Candelaria [7 ]
Gonzalez-Gay, Miguel A. [4 ,8 ]
Ferraz-Amaro, Ivan [2 ,7 ]
机构
[1] Hosp Doctor Negrin, Div Rheumatol, Las Palmas Gran Canaria 35010, Spain
[2] Hosp Univ Canarias, Div Rheumatol, San Cristobal De La Lagun 38320, Spain
[3] Hosp Univ Canarias, Div Cent Lab, San Cristobal De La Lagun 38320, Spain
[4] IIS Fdn Jimenez Diaz, Dept Rheumatol, Madrid 28040, Spain
[5] Univ La Laguna, Dept Basic Med Sci, Unit Physiol, San Cristobal De La Lagun 38200, Spain
[6] Hosp Insular, Div Rheumatol, Secc Ecograf, Las Palmas Gran Canaria 35016, Spain
[7] Univ Laguna ULL, Dept Internal Med, San Cristobal De La Lagun 38200, Spain
[8] Univ Cantabria, Dept Med & Psychiat, Santander 39005, Spain
关键词
3-nitrotyrosine; systemic lupus erythematosus; disease damage; cardiovascular disease; OXIDATIVE STRESS; BIOMARKER; MARKERS; DAMAGE; INDEX;
D O I
10.3390/antiox14060739
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
3-Nitrotyrosine (3-NT) is a product of tyrosine nitration mediated by reactive nitrogen species such as peroxynitrite anion and nitrogen dioxide. It serves as an indicator of inflammation, cell damage, and nitric oxide production. Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by multisystem involvement and increased oxidative stress. Notably, cardiovascular (CV) disease has emerged as the leading cause of mortality among SLE patients. Our objective was to investigate the association between serum 3-NT levels and a wide range of disease characteristics in patients with SLE, with a particular emphasis on CV comorbidity. A total of 214 patients with SLE were enrolled. The serum levels of 3-NT as well as the activity (SLEDAI) and damage index (SLICC-SDI) scores, full lipid profile, insulin resistance indices, and carotid subclinical atherosclerosis were assessed. Multivariable linear regression analysis was carried out to study the relationship between 3-NT and clinical and laboratory disease characteristics, especially focusing on CV comorbidities. Except for body mass index, which showed a significant positive correlation, the demographic data and traditional CV risk factors did not correlate with 3-NT. After multivariable adjustments, several disease characteristics, including the disease duration, activity and damage indices, and autoantibody profile, showed significant positive associations with 3-NT. Regarding CV characteristics, several lipid profile molecules showed significant relationships with 3-NT. This was not the case for insulin resistance and subclinical atherosclerosis. Remarkably, patients with a high CV risk by SCORE2 showed higher 3-NT values compared to those with a low risk, although after the multivariable adjustment, this relationship was attenuated (but still showed a trend). In conclusion, serum 3-NT levels demonstrated significant positive correlations with multiple disease characteristics, including the disease activity and damage and the autoantibody profile. The lipid pattern in the SLE subjects also significantly and independently correlated with the 3-NT values. Our findings highlight the pathophysiological role of 3-NT specifically, and peroxidation in general, in patients with SLE.
引用
收藏
页数:14
相关论文
共 30 条
[1]   3-Nitrotyrosine: A biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions [J].
Ahsan, Haseeb .
HUMAN IMMUNOLOGY, 2013, 74 (10) :1392-1399
[2]   3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases [J].
Bandookwala, Maria ;
Sengupta, Pinaki .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2020, 130 (10) :1047-1062
[3]   Increased Circulating Levels of 3-Nitrotyrosine Autoantibodies Marker for or Maker of Cardiovascular Disease? [J].
Daiber, Andreas ;
Muenzel, Thomas .
CIRCULATION, 2012, 126 (20) :2371-2373
[4]  
Davies MJ, 2024, Redox Biochemistry and Chemistry, V8, P100032, DOI [10.1016/j.rbc.2024.100032, 10.1016/j.rbc.2024.100032, DOI 10.1016/J.RBC.2024.100032]
[5]   Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus [J].
de Paz, Nayra Merino ;
Garcia-Gonzalez, Maria ;
Gomez-Bernal, Fuensanta ;
Quevedo-Abeledo, Juan C. ;
de Vera-Gonzalez, Antonia ;
Lopez-Mejias, Raquel ;
Abreu-Gonzalez, Pedro ;
Martin-Gonzalez, Candelaria ;
Gonzalez-Gay, Miguel A. ;
Ferraz-Amaro, Ivan .
ANTIOXIDANTS, 2023, 12 (08)
[6]  
Gilkeson G, 1999, J RHEUMATOL, V26, P318
[7]   The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus [J].
Gladman, D ;
Ginzler, E ;
Goldsmith, C ;
Fortin, P ;
Liang, M ;
Urowitz, M ;
Bacon, P ;
Bombardieri, S ;
Hanly, J ;
Hay, E ;
Isenberg, D ;
Jones, J ;
Kalunian, K ;
Maddison, P ;
Nived, O ;
Petri, M ;
Richter, M ;
SanchezGuerrero, J ;
Snaith, M ;
Sturfelt, G ;
Symmons, D ;
Zoma, A .
ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :363-369
[8]  
Gladman DD, 2002, J RHEUMATOL, V29, P288
[9]   SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe [J].
Hageman, Steven ;
Pennells, Lisa ;
Ojeda, Francisco ;
Kaptoge, Stephen ;
Kuulasmaa, Kari ;
de Vries, Tamar ;
Xu, Zhe ;
Kee, Frank ;
Chung, Ryan ;
Wood, Angela ;
McEvoy, John William ;
Veronesi, Giovanni ;
Bolton, Thomas ;
Dendale, Paul ;
Ference, Brian A. ;
Halle, Martin ;
Timmis, Adam ;
Vardas, Panos ;
Danesh, John ;
Graham, Ian ;
Salomaa, Veikko ;
Visseren, Frank ;
De Bacquer, Dirk ;
Blankenberg, Stefan ;
Dorresteijn, Jannick ;
Di Angelantonio, Emanuele ;
Achenbach, Stephan ;
Aleksandrova, Krasimira ;
Amiano, Pilar ;
Amouyel, Philippe ;
Andersson, Jonas ;
Bakker, Stephan J. L. ;
Costa, Rui Bebiano Da Providencia ;
Beulens, Joline W. J. ;
Blaha, Michael ;
Bobak, Martin ;
Boer, Jolanda M. A. ;
Bonet, Catalina ;
Bonnet, Fabrice ;
Boutron-Ruault, Marie-Christine ;
Braaten, Tonje ;
Brenner, Hermann ;
Brunner, Fabian ;
Brunner, Eric J. ;
Brunstrom, Mattias ;
Buring, Julie ;
Butterworth, Adam S. ;
Capkova, Nadezda ;
Cesana, Giancarlo ;
Chrysohoou, Christina .
EUROPEAN HEART JOURNAL, 2021, 42 (25) :2439-2454
[10]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725